Facebook Twitter LinkedIn Google Plus RSS

Eagle Pharmaceuticals announces pricing of initial public offering

By ,

Woodcliff Lake-based Eagle Pharmaceuticals announced Tuesday the pricing of its initial public offering of 3.35 million shares of common stock at a price to the public of $15 per share.

According to the release, the shares are scheduled to begin trading on the NASDAQ under the ticker symbol "EGRX" on Feb. 12. Eagle is offering all of the shares of common stock. It has also granted the underwriters a 30-day option to purchase up to an additional 502,500 shares of common stock. The offering is expected to close on Feb. 18.

Piper Jaffray & Co. and William Blair & Company, LLC are acting as joint book-running managers. Cantor Fitzgerald & Co. is acting as co-manager, the release said.


Solar sector in N.J. added – yes, added – jobs in 2013

EDA approves $81.9M in incentives for six new projects

ELEC to consider Christie campaign request to use, raise funds for subpoena response

Submit a nomination for General Counsel of the Year >

Also Popular on NJBIZ

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy